# Honokiol Inhibits Colorectal Cancer Cell Growth: Involvement of Hsp27 as a Molecular Target

**Authors:** Youngbin Kim, Hyeon Du Jang, Da Hyeon An, Hyun Seo Lee, Hong-Gyum Kim, Sun Eun Choi

PMC · DOI: 10.3390/cimb47110921 · 2025-11-05

## TL;DR

Honokiol, a natural compound, inhibits colorectal cancer cell growth by targeting Hsp27, a protein involved in cell survival.

## Contribution

This study identifies Hsp27 as a direct molecular target of honokiol in colorectal cancer cells.

## Key findings

- Honokiol suppresses CRC cell growth and induces G0/G1 cell cycle arrest.
- Honokiol binds to Hsp27 at specific residues, triggering apoptosis and reducing Hsp27 protein levels.
- Hsp27 knockdown significantly reduces anchorage-independent growth of CRC cells.

## Abstract

Background/Objectives: Honokiol (HK), a bioactive phenolic compound, exhibits significant anti-cancer properties. This study aimed to investigate the anti-cancer effects of HK in colorectal cancer (CRC) cells by focusing on its direct interaction with heat shock protein 27 (Hsp27) as a molecular target, and to elucidate the underlying mechanisms involved. Methods: HK was isolated via silica/ODS chromatography. Anchorage-independent growth of CRC cells was quantified using a soft agar assay with increasing HK concentrations. Apoptosis and cell cycle were analyzed by flow cytometry, and cell viability by MTS assay. Hsp27 binding to HK was validated by pull-down assay with HK-conjugated Sepharose 4B beads. Hsp27 knockdown was performed using lentiviral shRNA in CRC cells. Molecular docking of HK-Hsp27 interaction employed Schrödinger Suite 2016. Protein expressions, including chaperone and apoptotic proteins, were evaluated by Western blotting. Results: HK dose-dependently suppressed anchorage-independent growth of CRC cells and induced G0/G1 arrest. It triggered apoptosis through cytochrome c release, PARP cleavage, and Bcl-2 downregulation. HK directly bound to the α-crystallin domain of Hsp27 at Asn102 and His103 residues, confirmed by computational molecular docking and site-directed mutagenesis. Hsp27 knockdown in CRC cells dramatically reduced anchorage-independent growth. HK markedly decreased Hsp27 protein levels while having less effect on other heat shock proteins in CRC cells. Conclusions: HK exerts anti-cancer effects in CRC cells, associated with Hsp27 inhibition, resulting in suppressed cell growth and increased apoptosis. This interaction between HK and Hsp27 may support a mechanistic foundation supporting the potential utility of HK as a natural therapeutic agent for CRC.

## Linked entities

- **Genes:** HSPB1 (heat shock protein family B (small) member 1) [NCBI Gene 3315], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142]
- **Proteins:** HSPB1 (heat shock protein family B (small) member 1), Cyt-c-d (Cytochrome c distal), PARP1 (poly(ADP-ribose) polymerase 1), BCL2 (BCL2 apoptosis regulator)
- **Chemicals:** Honokiol (PubChem CID 72303), doxorubicin (PubChem CID 31703)
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** HSPB2 (heat shock protein family B (small) member 2) [NCBI Gene 3316] {aka HSP27, Hs.78846, LOH11CR1K, MKBP}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** CRC (MESH:D015179), cancer (MESH:D009369)
- **Chemicals:** silica (MESH:D012822), phenolic (-), Sepharose (MESH:D012685), agar (MESH:D000362), HK (MESH:C005499)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12650836/full.md

---
Source: https://tomesphere.com/paper/PMC12650836